Jun. 6 at 10:10 AM
$INBS Like the 2 June update on the last trial ending in late July.
Share count now up to 2.38 Million, don't you just hate dilution efforts
with respect to market cap, share price targets?
But with a market cap of just under
$6 Mil on 2.38 Mil shares?
$2.45/sh?
Can still see them getting up to around
$7.5 to
$8 range IF the fda decision goes in their favor. Heres hoping there is minimal to no more
dilution between now and then, but doubt we get that lucky..
PS: got to like the chart formation if you are looking to add some more
